These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 151530)

  • 21. [Effects of melatonin on muscle contractility and neuromuscular blockade produced by muscle relaxants].
    Uchida K; Aoki T; Satoh H; Tajiri O
    Masui; 1997 Feb; 46(2):205-12. PubMed ID: 9071104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro response of neuromuscular blockers after chronic carbamazepine treatment in rats.
    Nguyen A; Ramzan I
    Pharmazie; 2000 Dec; 55(12):957. PubMed ID: 11189879
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuromuscular blockade in adult intensive care.
    Topulos GP
    New Horiz; 1993 Aug; 1(3):447-62. PubMed ID: 7922424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neuromuscular blocking actions of pancuronium.
    Norman J; Katz RL; Seed RF
    Anaesthesia; 1970 Jan; 25(1):130. PubMed ID: 4244174
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of propranolol on the isolated phrenic nerve-diaphragm preparation of the rat.
    Paradelis AG; Theocharidis NC; Logaras G
    Arzneimittelforschung; 1973 Jan; 23(1):38-40. PubMed ID: 4353375
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacology of neuromuscular blocking agents in the intensive care unit.
    Hanson CW
    Crit Care Clin; 1994 Oct; 10(4):779-97. PubMed ID: 8000926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of myorelaxants in anesthesia.
    Flood P
    Curr Opin Pharmacol; 2005 Jun; 5(3):322-7. PubMed ID: 15907920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of tranquilizing and antidepressive agents on the summation of impulses in the central nervous system].
    Zakusov VV
    Farmakol Toksikol; 1971; 34(1):7-9. PubMed ID: 4327456
    [No Abstract]   [Full Text] [Related]  

  • 29. [A nondepolarizing muscle relaxant with rapidly developing and short-term action].
    Danilov AF; Zhabko EP
    Eksp Klin Farmakol; 1998; 61(5):18-20. PubMed ID: 9854626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The depolarizing and non-depolarizing neuromuscular blocking agents.
    Lamid S; Wang RI
    Wis Med J; 1974 Jan; 73(1):S15-6. PubMed ID: 4273039
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tubocurarine and psychopharmacologic agents. IV. Thymeretic antidepressants].
    Sansone M; Aulisio GA; Marino A
    Boll Soc Ital Biol Sper; 1967 Mar; 43(5):246-9. PubMed ID: 6060498
    [No Abstract]   [Full Text] [Related]  

  • 32. Cellular mechanisms of atracurium-induced tetanic fade in the isolated rat muscle.
    Nascimento DC; Serra CS; Oliveira AC
    Basic Clin Pharmacol Toxicol; 2004 Jul; 95(1):9-14. PubMed ID: 15245570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An overview of the pharmacology of rocuronium bromide in experimental animals.
    Marshall RJ; Muir AW; Sleigh T; Savage DS
    Eur J Anaesthesiol Suppl; 1994; 9():9-15. PubMed ID: 7925216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and experimental studies on the mechanism of neuromucular blockade by chloroquine diorotate].
    Tseng J
    Masui; 1971 Jun; 20(6):491-503. PubMed ID: 4254543
    [No Abstract]   [Full Text] [Related]  

  • 35. Frequency dependence of neuromuscular block.
    Storella RJ; Bierkamper GG
    Proc West Pharmacol Soc; 1985; 28():205-8. PubMed ID: 2866534
    [No Abstract]   [Full Text] [Related]  

  • 36. Surrogate endpoints and neuromuscular recovery.
    Kopman AF
    Anesthesiology; 1997 Nov; 87(5):1029-31. PubMed ID: 9366449
    [No Abstract]   [Full Text] [Related]  

  • 37. A partial pharmacologic profile of the response to neuromuscular blocking agents as modified by sodium L-thyroxine.
    TABACHNICK II; THORSTAD JA; WAGNER J; PARKER RF
    Arch Int Pharmacodyn Ther; 1958 Mar; 114(2):210-6. PubMed ID: 13534812
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of histamine on neuromyal blocking agents.
    SCHENK EA; ANDERSON EG
    J Pharmacol Exp Ther; 1958 Feb; 122(2):234-8. PubMed ID: 13514611
    [No Abstract]   [Full Text] [Related]  

  • 39. Doxapram and the neuromuscular junction.
    Fauvel NJ; Feldman SA
    Br J Anaesth; 1990 Feb; 64(2):256-7. PubMed ID: 2317431
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical pharmacology of the neuromuscular junction.
    Nastuk WL
    Anesthesiology; 1969 Jul; 31(1):3-4. PubMed ID: 5787182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.